Skip to main content

Advertisement

SpringerLink
Log in

Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth

  • Matters Arising
  • Published:

From Nature

View current issue Submit your manuscript

The Original Article was published on 03 March 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ma, S. et al. Hippo signalling maintains ER expression and ER+ breast cancer growth. Nature, https://doi.org/10.1038/s41586-020-03131-5 (2021).

  2. Britschgi, A. et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature 541, 541–545 (2017).

    Article  ADS  CAS  Google Scholar 

  3. Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by LATS and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 24, 72–85 (2010).

    Article  CAS  Google Scholar 

  4. Totaro, A., Panciera, T. & Piccolo, S. YAP/TAZ upstream signals and downstream responses. Nat. Cell Biol. 20, 888–899 (2018).

    Article  CAS  Google Scholar 

  5. Rossi, A. et al. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 524, 230–233 (2015).

    Article  ADS  CAS  Google Scholar 

  6. Duss, S. et al. Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells. Breast Cancer Res. 16, R60 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland

    Adrian Britschgi, Joana Pinto Couto & Mohamed Bentires-Alj

Authors
  1. Adrian Britschgi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joana Pinto Couto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Bentires-Alj
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.B., J.P.C. and M.B.-A. wrote the response. The author list for this Reply differs from the author list of the original Article to accelerate the response to the Comment.

Corresponding author

Correspondence to Mohamed Bentires-Alj.

Ethics declarations

Competing interests

A.B. is an employee of Roche Pharma AG and J.P.C. of Novartis. M.B.-A. and A.B. are inventors on the US patent WO2016046768A1 ‘Lats and breast cancer’.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Britschgi, A., Couto, J.P. & Bentires-Alj, M. Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth. Nature 591, E11–E12 (2021). https://doi.org/10.1038/s41586-020-03132-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41586-020-03132-4

  • Springer Nature Limited

Search

Navigation